BCL6 and B-cell non-Hodgkin lymphoma: Beyond B cell lymphomas, BCL6 inhibition also impacts Tfh cells and GC B cells and may regulate immune responses during infectious disease (48, 64), auto-immunity (47), or allo-immune responses (67, 69, 70).